PACS Group, Inc. announces NYSE Listing Extension through November 19, 2025, to complete financial statement restatement and regain compliance.
Company highlights strong business momentum and operational position with a growing portfolio of healthcare facilities.
PACS expects to report record revenue and Adjusted EBITDA for the first six months of 2025 upon becoming current with SEC filings.
NYSE Listing Extension
Additional trading period granted by NYSE provides time to complete financial statement restatement and regain compliance.
Solid Business Momentum
PACS benefiting from strong business momentum with a growing portfolio of high-quality healthcare facilities.
Record Revenue Expectation
Expectation to report record revenue and Adjusted EBITDA for the first six months of 2025 upon SEC filing compliance.
Strategic Growth Plans
Company actively working on strategies to accelerate growth and drive value creation for stakeholders.
- PACS Group has added 96 healthcare facilities since Q2 2024, operating 316 facilities with skilled nursing and assisted living beds across 17 states as of June 30, 2025.
- Key operating metrics show strong performance with high CMS QM ratings and above-industry average occupancies.
- Cash reserves increased to $294.2 million as of June 30, 2025, supporting growth initiatives and business plan execution.
PACS Group's focus on compliance enhancement, operational growth, and strategic value creation positions it for future success in the healthcare industry.